Skip to content
HowShorted

Puma Biotechnology Inc short interest in 2024

In 2024, Puma Biotechnology Inc's disclosed short interest ran from 6.34% of shares outstanding on 12 Jan 2024 to 6.13% on 31 Dec 2024, a change of -0.21 percentage points. The year's high was 8.60% on 29 Feb 2024 and its low 5.21% on 31 May 2024, averaging 6.78% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.42 days on 31 Oct 2024. Full history: Puma Biotechnology Inc.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Puma Biotechnology Inc in 2024

2024 in figures

Start of year
6.34% (12 Jan 2024)
End of year
6.13% (31 Dec 2024)
Change
-0.21 pp
High
8.60% (29 Feb 2024)
Low
5.21% (31 May 2024)
Average
6.78%
Highest days to cover
16.42 (31 Oct 2024)
SEC filings marked
8

Every report in 2024

Puma Biotechnology Inc short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20246.34%7.60
31 Jan 20246.74%7.50
15 Feb 20247.55%5.18
29 Feb 20248.60%5.1110-K filed, results (8-K)
15 Mar 20247.01%5.10
28 Mar 20246.92%4.30
15 Apr 20246.99%9.49
30 Apr 20246.45%12.10
15 May 20246.31%8.7710-Q filed, results (8-K)
31 May 20245.21%4.99
14 Jun 20245.59%9.77
28 Jun 20246.07%2.82
15 Jul 20247.87%9.19
31 Jul 20247.79%11.45
15 Aug 20248.16%8.7310-Q filed, results (8-K)
30 Aug 20247.09%9.14
13 Sep 20247.37%12.79
30 Sep 20246.96%11.30
15 Oct 20247.37%15.49
31 Oct 20246.50%16.42
15 Nov 20246.08%3.8610-Q filed, results (8-K)
29 Nov 20245.72%7.20
13 Dec 20245.92%6.08
31 Dec 20246.13%5.55

See also: Puma Biotechnology Inc's full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.